Please login to the form below

Not currently logged in
Email:
Password:

Pfizer veteran joins Dynavax board

Natale Ricciardi spent 39 years at pharma giant

Dynavax Natale RicciardiNatale Ricciardi has joined the board of Dynavax Technologies two years after retiring from Pfizer.

Ricciardi spent 39 years at Pfizer, advancing to president of the pharma giant's global manufacturing business and senior VP of its North American operations.

He was also a member of the Pfizer executive leadership team when he retired in 2011.

Dynavax, which focuses on developing products to prevent and treat infectious and inflammatory diseases, will benefit from this senior experience as it looks to bring to market its lead product candidate, the hepatitis B vaccine Heplisav.

"On behalf of Dynavax, we are delighted to welcome Nat to the board,” said Arnold Oronsky, chairman of the board at Dynavax.

“His experienced leadership, particularly in global manufacturing, will provide valuable insight to the company and we look forward to his contributions."

10th July 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics